Evidence map›Paper›PMID 29931197›Full record

ArticleCardiovascular research2018

Decreased mitochondrial respiration in aneurysmal aortas of Fibulin-4 mutant mice is linked to PGC1A regulation.

Ingrid van der Pluijm, Joyce Burger, Paula M van Heijningen, Arne IJpma, Nicole van Vliet, Chiara Milanese, Kees Schoonderwoerd, Willem Sluiter, Lea-Jeanne Ringuette, Dirk H W Dekkers and 14 more

Abstract read
In one paragraph

Article in Cardiovascular research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Aging-AssociatedJournal of the American Heart Association · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Role of theGenes · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Bioengineered vascular grafts with a pathogenicScience translational medicine · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Ingrid van der PluijmDepartment of Vascular Surgery, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Joyce BurgerDepartment of Molecular Genetics, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Paula M van HeijningenDepartment of Molecular Genetics, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Arne IJpmaClinical Bioinformatics Unit, Department of Pathology, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Nicole van VlietDepartment of Molecular Genetics, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Chiara MilaneseDepartment of Molecular Genetics, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Kees SchoonderwoerdDepartment of Clinical Genetics, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Willem SluiterDepartment of Molecular Genetics, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Lea-Jeanne RinguetteDepartment of Anatomy and Cell Biology, McGill University, Rue University, Montréal, QC H3A 0C7, Canada.
Dirk H W DekkersProteomics Center, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Ivo QueDepartment of Radiology, Leiden University Medical Center, Albinusdreef 2, ZA Leiden, The Netherlands.
Erik L KaijzelDepartment of Radiology, Leiden University Medical Center, Albinusdreef 2, ZA Leiden, The Netherlands.
Luuk Te RietDepartment of Vascular Surgery, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Elena G MacFarlaneDepartment of Surgery, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore, MD, USA.
Devashish DasDepartment of Molecular Genetics, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Reinier van der LindenStem cell Institute, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Marcel VermeijDepartment of Pathology, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Jeroen A DemmersProteomics Center, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Pier G MastroberardinoDepartment of Molecular Genetics, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Elaine C DavisDepartment of Anatomy and Cell Biology, McGill University, Rue University, Montréal, QC H3A 0C7, Canada.
Hiromi YanagisawaLife Science Center, Tsukuba Advanced Research Alliance, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.
Harry C DietzDepartment of Surgery, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore, MD, USA.
Roland KanaarDepartment of Radiation Oncology, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.
Jeroen EssersDepartment of Vascular Surgery, Erasmus MC, Wytemaweg 80, CN Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Thoracic aortic aneurysms are a life-threatening condition often diagnosed too late. To discover novel robust biomarkers, we aimed to better understand the molecular mechanisms underlying aneurysm formation. Methods and results: In Fibulin-4R/R mice, the extracellular matrix protein Fibulin-4 is 4-fold reduced, resulting in progressive ascending aneurysm formation and early death around 3 months of age. We performed proteomics and genomics studies on Fibulin-4R/R mouse aortas. Intriguingly, we observed alterations in mitochondrial protein composition in Fibulin-4R/R aortas. Consistently, functional studies in Fibulin-4R/R vascular smooth muscle cells (VSMCs) revealed lower oxygen consumption rates, but increased acidification rates. Yet, mitochondria in Fibulin-4R/R VSMCs showed no aberrant cytoplasmic localization. We found similar reduced mitochondrial respiration in Tgfbr-1M318R/+ VSMCs, a mouse model for Loeys-Dietz syndrome (LDS). Interestingly, also human fibroblasts from Marfan (FBN1) and LDS (TGFBR2 and SMAD3) patients showed lower oxygen consumption. While individual mitochondrial Complexes I-V activities were unaltered in Fibulin-4R/R heart and muscle, these tissues showed similar decreased oxygen consumption. Furthermore, aortas of aneurysmal Fibulin-4R/R mice displayed increased reactive oxygen species (ROS) levels. Consistent with these findings, gene expression analyses revealed dysregulation of metabolic pathways. Accordingly, blood ketone levels of Fibulin-4R/R mice were reduced and liver fatty acids were decreased, while liver glycogen was increased, indicating dysregulated metabolism at the organismal level. As predicted by gene expression analysis, the activity of PGC1α, a key regulator between mitochondrial function and organismal metabolism, was downregulated in Fibulin-4R/R VSMCs. Increased TGFβ reduced PGC1α levels, indicating involvement of TGFβ signalling in PGC1α regulation. Activation of PGC1α restored the decreased oxygen consumption in Fibulin-4R/R VSMCs and improved their reduced growth potential, emphasizing the importance of this key regulator. Conclusion: Our data indicate altered mitochondrial function and metabolic dysregulation, leading to increased ROS levels and altered energy production, as a novel mechanism, which may contribute to thoracic aortic aneurysm formation.

Indexed as

Energy MetabolismMutationAnimalsAorta, ThoracicAortic Aneurysm, ThoracicCell RespirationCells, CulturedDisease Models, AnimalExtracellular Matrix ProteinsHumansMice, Inbred C57BLMice, KnockoutMitochondria, MuscleMuscle, Smooth, VascularMyocytes, Smooth MusclePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaEFEMP2 protein, humanExtracellular Matrix ProteinsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseReactive Oxygen SpeciesReceptor, Transforming Growth Factor-beta Type ITgfbr1 protein, mouse

Identifiers

PMID29931197
PMCPMC6198735

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.